Navigation Links
2008 Ullyot Public Affairs Lecture
Date:11/10/2008

The Ullyot Public Affairs Lecture was established in 1990 to emphasize to the general public the positive role that the chemical and molecular sciences play in our lives. Ullyot Lectures are held annually and are open to the public. Ullyot lecturers are distinguished in their fields, nationally recognized, and able to communicate to a nonscientific audience.

This year's lecture will be given by Bernard Bigot, high commissioner of the French Atomic Energy Commission and a professor of chemistry and physics at the cole Normale Suprieure de Lyon. He is the former auditor for the Higher Studies Institute of the French Defense Ministry.

For four years he was director of the Catalysis Research Institute at the Centre National de la Recherche Scientifique in Lyon-Villeurbanne, and for fifteen years he led the Theoretical Chemistry Laboratory at the cole Normale Suprieure de Lyon.

He has authored 70 scientific publications in the fields of quantum physical chemistry applied to photochemistry, heterogeneous catalysis, reactivity in liquid phase, and nuclear energy.


'/>"/>

Contact: Sarah Reisert
sreisert@chemheritage.org
215-873-8263
Chemical Heritage Foundation
Source:Eurekalert

Page: 1

Related biology news :

1. Bridging public and private research on bioinformatics and proteomics
2. Indiana University research at American Public Health Association meeting
3. BIO-key(R) Announces Additional $245,000 in Third Quarter Public Safety Orders
4. Stevens strengthens Dominican Republics Early Warning System for Inundations
5. American Physical Society announces Physics, a new, free, online publication
6. FAS honors Mark D. Levine with 2008 Public Service Award
7. Healthy Minds Across America features 48 public forums on mental health research, Sept. 14
8. Springer bee expert Juergen Tautz wins prize for public communication
9. EMBO recognizes German zoologist for public communication
10. Many US public schools in air pollution danger zone
11. New book tutors future presidents and public on science behind the headlines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/14/2016)... BioCatch ™, the global ... the appointment of Eyal Goldwerger as CEO. ... Goldwerger,s leadership appointment comes at a time of significant ... of its platform at several of the world,s largest ... unique cognitive and physiological factors, is a winner of ...
(Date:3/31/2016)... BOCA RATON, Florida , March 31, 2016 /PRNewswire/ ... LEGX ) ("LegacyXChange" or the "Company") ... presentation for potential users of its soon to be ... The video ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also ... by the use of DNA technology to an industry ...
(Date:3/29/2016)... BOCA RATON, Florida , March 29, 2016 /PRNewswire/ ... ("LegacyXChange" or the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect ... Synthetic DNA in ink used in a variety of ... preventing theft. Buyers of originally created collectibles from athletes ... authenticity through forensic analysis of the DNA. ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... June 27, 2016 , ... Parallel 6 , the leading software as ... Clinical Reach Virtual Patient Encounter CONSULT module which enables both audio and video ... trial team. , Using the CONSULT module, patients and physicians can schedule a face ...
(Date:6/27/2016)... --  Ginkgo Bioworks , a leading organism design ... awarded as one of the World Economic Forum,s ... innovative companies. Ginkgo Bioworks is engineering biology to ... in the nutrition, health and consumer goods sectors. ... including Fortune 500 companies to design microbes for ...
(Date:6/24/2016)... ... , ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical ... mesothelioma. Their findings are the subject of a new article on the Surviving Mesothelioma ... in the blood, lung fluid or tissue of mesothelioma patients that can help point ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
Breaking Biology Technology: